おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
ViroXis
company
About
ViroXis, a bio-pharmaceutical company, develops botanical pharmaceuticals derived from sandalwood oil.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $1.01M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2006
- Number Of Employee
- 11 - 50
- Operating Status
- Close
ViroXis is a bio-pharmaceutical company focused on developing and commercializing innovative, properietary, botanical pharmaceuticals derived from Sandalwood Oil. The hardwood oils of the East Indian and West Australian sandalwood trees, S.album and S. spicatum, have a long and extensive history of traditional use for a variety of conditions, including the successful treatment of various skin disorders, including skin viral and difficult-to-treat microbial infections.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$1.01M
ViroXis has raised a total of
$1.01M
in funding over 2 rounds. Their latest funding was raised on
Mar 31, 2012 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 31, 2012 | Series Unknown | $1.01M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
ViroXis is funded by 1 investors.
Greer Capital Advisors
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Greer Capital Advisors
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
